TITLE

Controlled-release levodopa methyl ester/ benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats

AUTHOR(S)
Xinxin Yang; Ruiyuan Zheng; Yunpeng Cai; Meiling Liao; Weien Yuan; Zhenguo Liu
PUB. DATE
January 2012
SOURCE
International Journal of Nanomedicine;2012, Vol. 7, p2077
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
82508951

 

Related Articles

  • Levodopa.  // Reactions Weekly;Apr2014, Vol. 1497 Issue 1, p25 

    The article presents two case studies of men diagnosed with levodopa-induced dyskinesias developed while receiving levodopa.

  • Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Picconi, Barbara; Bagetta, Vincenza; Ghiglieri, Veronica; Paillè, Vincent; Di Filippo, Massimiliano; Pendolino, Valentina; Tozzi, Alessandro; Giampà, Carmela; Fusco, Francesca R.; Sgobio, Carmelo; Calabresi, Paolo // Brain: A Journal of Neurology;Feb2011, Vol. 134 Issue 2, p375 

    The aim of the present study was to evaluate the role of the nitric oxide/cyclic guanosine monophosphate pathway in corticostriatal long-term depression induction in a model of levodopa-induced dyskinesia in experimental parkinsonism. Moreover, we have also analysed the possibility of targeting...

  • Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Bezard, Erwan; Ferry, Sandrine; Mach, Ulrich; Stark, Holger; Leriche, Ludovic; Boraud, Thomas; Gross, Christian; Sokoloff, Pierre // Nature Medicine;Jun2003, Vol. 9 Issue 6, p762 

    In monkeys rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), expression of the dopamine D[SUB3] receptor was decreased. However, levodopa-induced dyskinesia (LID), similar to the debilitating and pharmacoresistant involuntary movements elicited after long-term...

  • Levodopa.  // Reactions Weekly;May2014, Vol. 1503 Issue 1, p26 

    An abstract of the article "Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients," by M. Politis and colleagues is presented.

  • Levodopa.  // Reactions Weekly;9/7/2013, Issue 1468, p27 

    The article describes a case of levodopa-induced dyskinesia in a woman who was diagnosed with Parkinson's disease.

  • Does Levodopa Accelerate Parkinson's Disease? Simuni, T.; Stern, M.B. // Drugs & Aging;1999, Vol. 14 Issue 6, p399 

    Therapeutic options for the treatment of Parkinson's disease (PD) have expanded tremendously over the last 5 years, although levodopa remains the gold standard of therapy. A major therapeutic controversy has been the question of levodopa's potential to cause toxic effects on nigrostriatal cells,...

  • Levodopa.  // Reactions Weekly;10/5/2013, Issue 1472, p26 

    An abstract of the article "Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism," by P. Pita Lobo and colleagues is presented.

  • 1997 Royal College mealist in medicine.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS112 

    Presents an abstract of the research manuscript `Experimental investigation of levodopa-induced dyskinesia in a primate model of Parkinsonism,' by P.J. Blanchet.

  • Glutamate NMDA receptor dysregulation in Parkinson’s disease with dyskinesias. Ahmed, Imtiaz; Bose, Subrata K.; Pavese, Nicola; Ramlackhansingh, Anil; Turkheimer, Federico; Hotton, Gary; Hammers, Alexander; Brooks, David J. // Brain: A Journal of Neurology;Apr2011, Vol. 134 Issue 4, p979 

    Levodopa-induced dyskinesias are a common complication of long-term therapy in Parkinson’s disease. Although both pre- and post-synaptic mechanisms seem to be implicated in their development, the precise physiopathology of these disabling involuntary movements remains to be fully...

  • NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients. Mellone, Manuela; Stanic, Jennifer; Hernandez, Ledia F.; Iglesias, Elena; Zianni, Elisa; Longhi, Annalisa; Prigent, Annick; Picconi, Barbara; Calabresi, Paolo; Hirsch, Etienne C.; Obeso, Jose A.; Di Luca, Monica; Gardoni, Fabrizio // Frontiers in Cellular Neuroscience;Jul2015, Vol. 9, p1 

    Levodopa-induced dyskinesias (LIDs) are major complications in the pharmacological management of Parkinson's disease (PD). Abnormal glutamatergic transmission in the striatum is considered a key factor in the development of LIDs. This work aims at: (i) characterizing N-methyl-D-aspartate (NMDA)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics